BlackRock Institutional Trust’s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) SKBI Stock Holding History
Bought
Maintained
Sold
Other funds holding SKBI
BlackRock Institutional Trust's SKBI Position: Q4 2015 in Review
BlackRock Institutional Trust sold out of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) in Q4 2015, closing a stake of 175,708 shares — an estimated $167K sold.
BlackRock Institutional Trust first reported a position in SKBI in Q4 2013 and held it in 8 quarters. The position peaked at $1.23M in Q2 2014. 1 fund tracked by Wall St. Rank holds SKBI as of Q4 2015.
- BlackRock Institutional Trust reported no remaining SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position as of Q4 2015 after selling out during the quarter.
- BlackRock Institutional Trust sold 175,708 SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) shares in Q4 2015, an estimated $167K.
- BlackRock Institutional Trust first reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in Q4 2013 and held it in 8 quarters.
- BlackRock Institutional Trust's SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position peaked at $1.23M in Q2 2014.
- 1 fund tracked by Wall St. Rank held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) as of Q4 2015.
Based on BlackRock Institutional Trust's 13F filing for Q4 2015, filed 11 Feb 2016.